Palo Alto – February 12, 2026 – WCP is delighted to release the Life Sciences Market Update for Q4 2025, authored by Joseph Galasso, Strategic Advisor to WCP and PhD Candidate at UCLA, by senior banker Juliesta Sylvester PhD and by analyst Ted Celentino.
The report covers the following key points and more:
- What drives value in life sciences tools: workflow adoption, installed base / pull-through, and data integration.
- AI in practice: data quality beats generic AI capabilities, and products with AI built into the workflow are pulling ahead of bolt-ons.
- Who’s buying: strategic acquirers made 88% of life sciences acquisitions in 2025.
- Funding: Q4 2025 venture funding for life sciences fell slightly to $471M, ~12% below Q4 2024 levels, due to high interest rates and investor focus on AI.
- Key Challenges: Embedding AI requires new operating discipline: data readiness, validation, and workflow ownership.
Get the report here:
Woodside Capital Partners is a leading corporate finance advisory firm for tech companies in M&A and financings in the $30M –$500M enterprise value segment. The firm has worked with extraordinary entrepreneurs and investors since 2001, providing ultra-personalized service to its clients. Our team has global vision and reach, and has completed hundreds of successful engagements. We have deep industry knowledge and extensive domain and transaction experience in these and other sectors: Artificial Intelligence, CyberSecurity, HR Tech, Digital Advertising and Marketing, Autonomous Vehicles, ADAS, Computer Vision, Aerospace and Defense, CloudTech, Enterprise Software, IT Services, Information Security, FinTech, Internet of Things, Networking / Infrastructure, Robotics, Semiconductors, Quantum, Energy Storage, Digital Health & Virtual Care, Diagnostic, Medical Devices & Precision Medicine, Healthcare IT & Data Analytics Platforms, AI & Automation in Clinical Decision Support, Revenue Cycle Management & Financial Ops, Behavioral & Mental Health Tech, Value-Based Care & Preventive/Wellness Platforms, Healthcare Infrastructure & Cybersecurity. Woodside Capital Partners is a specialist in cross-border transactions, and has extensive relationships among venture capitalists, private equity investors, and corporate executives from Global 1000 companies.
Questions? Please contact Juliesta Sylvester PhD, Managing Director, Woodside Capital Partners at jsylvester@woodsidecap.com.